• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Antiemetics Market Insights, Potential Business Strategies, Mergers and Acquisitions, Revenue Analysis to 2025

Share:

March 9, 2020

Global antiemetics market report scope includes detailed study covering underlying factors influencing the industry trends.

Global antiemetics market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The antiemetics market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

Global antiemetics market is segregated on the basis of drug as, 5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines, Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, and others. Based on application, the global antiemetics market is segmented as Chemotherapy, Motion Sickness, Gastroenteritis, General Anaesthetics, Opioid Analgesics, Dizziness, Pregnancy, Food Poisoning, Emotional Stress, and others.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Identification of novel drug targets and usage of new drug delivery to improve compliance of patients are the additional factors contributing significantly in the industry growth rate between 2018 and 2024. However, the antiemetics drugs in clinical phase needs more advancement for commercializing the product. Also, lack of animal model to accurately mimic the human responses for the therapy may restrict the industry growth.

The global antiemetics market share is expected to witness exponential growth rate during the foreseeable time frame. This growth can be primarily credited to rising number of patients diagnosed with cancer disease. Moreover, extensive research being carried out to modernize antiemetic drug therapy will further improve the industry size.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global antiemetics market share. Major industry players with significant revenue share include Eli Lilly and Company, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Sanofi-Aventis, Pfizer, Astellas Pharma, Baxter International, and Johnson & Johnson.

The report covers:

o Global antiemetics market sizes from 2015 to 2024, along with CAGR for 2018-2024.
o Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024

o Global antiemetics market trends, covering comprehensive range of consumer trends & manufacturer trends
o Value chain analysis covering participants from raw material suppliers to the downstream buyer in the antiemetics market
o Major market opportunities and challenges in forecast timeframe to be focused
o Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
o Comprehensive company profiles of the key industry players

Competitive Rivalry

Eli Lilly and Company, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Sanofi-Aventis, Pfizer, Astellas Pharma, Baxter International, and Johnson & Johnson are among the major players in the global antiemetics market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Antiemetics Market has been segmented as below:

The Antiemetics Market is segmented on the lines of Antiemetics Market, By Drug, Antiemetics Market, By Application and Antiemetics Market, By Region.

Antiemetics Market, By Drug this market is segmented on the basis of Chemotherapy, Motion sickness, Gastroenteritis, General anaesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress and Others. Antiemetics Market, By Application this market is segmented on the basis of Chemotherapy, Motion sickness, Gastroenteritis, General anaesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress and Others. Antiemetics Market, By Region this market is segmented on the basis of North America, Europe, Asia Pacific and Rest of World.

Source: Openpr

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • XRHealth, VirZOOM team-up to bring VR exercises to hospitals, rehab centers and patientsXRHealth, VirZOOM team-up to bring VR exercises to hospitals, rehab centers and patients
  • OCD-focused platform NOCD raises $35M and more digital health fundingsOCD-focused platform NOCD raises $35M and more digital health fundings
  • Rafarma Finalizes Acquisition of Laskavy Patents, Prepared as Global Markets ResetRafarma Finalizes Acquisition of Laskavy Patents, Prepared as Global Markets Reset
  • Fitbit Data Suggests People with COVID-19 Experience Lingering Health EffectsFitbit Data Suggests People with COVID-19 Experience Lingering Health Effects
  • Hospital and Health System M&A in 2023: Financial Distress Drive Market Reorganization and PartnershipsHospital and Health System M&A in 2023: Financial Distress Drive Market Reorganization and Partnerships
  • Health Insurance Innovations acquires direct-to-consumer platformHealth Insurance Innovations acquires direct-to-consumer platform
  • TxCell terminates its OCABSA financing program following closing of the acquisition by Sangamo of a majority stake in TxCellTxCell terminates its OCABSA financing program following closing of the acquisition by Sangamo of a majority stake in TxCell
  • Hong Kong-Based AI Developer Creates COVID-19 Survival CalculatorHong Kong-Based AI Developer Creates COVID-19 Survival Calculator

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications